Dear Colleagues,
My question is; do users of the BNP or NT proBNP assay
provide elevated 'cut offs' for patients with CKD
including renal dialysis patients?
If so could you point me in the right direction of the
evidence base.
Finally, am I correct in stating that BNP is less
affected by renal failure than NY pro BNP?
Thank you
Jane
Grade A trainee
Dr. Jane Dalley
Department of Clinical Biochemistry
Central Pathology Laboratory
University Hospital of North Staffordshire
Hartshill Road
Stoke-on-Trent
Staffordshire
ST4 7PA
Tel: 01782 554002
___________________________________________________________
Yahoo! Answers - Got a question? Someone out there knows the answer. Try it
now.
http://uk.answers.yahoo.com/
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
|